Stock Market & Financial Investment News

News Breaks February 5, 2013 06:36 EDT NBIX Neurocrine Biosciences initiated with a Buy at Lazard Capital Target $13. News For NBIX From The Last 14 Days Check below for free stories on NBIX the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. There are no results for NBIX Sign up for a free trial to see the rest of the stories you've been missing.